LBRX LB Pharmaceuticals Inc
34.16USD-0.29%Mkt Cap: 1.10B $P/E: 341.601d ago
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small mole…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap1.10B USD
Enterprise Value782.63M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-25.20M USD
Revenue/Share—
Last Price34.16 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)341.60
P/E (Forward)-6.62
PEG—
EV/EBITDA-8.60
EV/Revenue—
P/S—
P/B2.96
EPS (TTM)0.10
EPS (Forward)-5.17
52W Range
14.3255% of range50.16
52W High50.16 USD
52W Low14.32 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.37%
ROA-8.05%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.21M USD
CapEx (TTM)52.00K USD
FCF Margin—
FCF Yield-4.89%
Net Debt-322.57M USD
Net Debt/EBITDA3.54
Balance Sheet
Debt/Equity0.01
Current Ratio15.08
Quick Ratio13.91
Book Value/Sh11.59 USD
Cash/Share10.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)57.30 USD
Upside (mean)+67.7%
Target Range35.00 USD – 80.00 USD
35.00+67.7% to mean80.00
# Analysts10
Ownership
Shares Out.32.26M
Float26.46M
Insiders0.24%
Institutions102.44%
Short Interest
Short Ratio21.0d
Short % Float20.49%
Short % Out.17.41%
Shares Short5.62M
Short (prev mo.)5.16M
Technical
SMA 5043.86 (-22.1%)
SMA 20030.98 (+10.3%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)342.06K
Avg Vol (10d)438.60K
Technical Indicators
RSI (14)26.0
MACD-2.6381
MACD Signal-1.9967
MACD Hist.-0.6414
BB Upper47.32 USD
BB Middle39.84 USD
BB Lower32.36 USD
BB Width37.54%
ATR (14)2.088 USD
Vol Ratio (20d)1.06x